- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 16-06-2026: Press Release
16-06-2026 | 04:30 pm
16-06-2026 | 04:30 pm
Zydus Lifesciences has completed its acquisition of Assertio Holdings via a $23.50/share cash tender offer. Assertio is now a wholly-owned subsidiary, delisted from Nasdaq. This move expands Zydus's portfolio.
No comments yet. Be the first to comment!